Medindia

X

FDA issues warnings on Three Popular Asthma drug labels

by Medindia Content Team on  May 16, 2006 at 3:35 PM Drug News   - G J E 4
FDA issues warnings on Three Popular Asthma drug labels
The U.S. Food and Drug Administration has updated the product labels for three widely known asthma drugs, which will now carry the warnings that the drugs may enhance the risk of suffering a severe asthma attack that could also turn fatal.
Advertisement

The drugs that now carry the updated product labels will be the powerful bronchodilator medicines Advair and Serevent, made by GlaxoSmithKline Plc and Foradil from Novartis AG .The FDA has further advised that these inhaled drugs should only be used after other types of inhaled drugs like corticosteroids, have failed to alleviate the asthma attack.

Advertisement
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All